Drug Patent List
Oppositions
Newsletter
Weekly Digest

Pharsight

Testosterone Cypionate Patent Expiration

Testosterone Cypionate was first introduced by Slayback Pharma Llc in its drug Testosterone Cypionate on Jun 2, 2022. 15 different companies have introduced drugs containing Testosterone Cypionate.


Testosterone Cypionate Patents

Given below is the list of patents protecting Testosterone Cypionate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Testosterone Cypionate US11311554 Pharmaceutical compositions of testosterone Mar 25, 2039 Slayback Pharma Llc
Testosterone Cypionate US11642355 Pharmaceutical compositions of testosterone Mar 25, 2039 Slayback Pharma Llc


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Testosterone Cypionate's patents.

Given below is the list recent legal activities going on the following patents of Testosterone Cypionate.

Event Date Patent/Publication
Patent litigations
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 19 Jan, 2024 US11642355
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 19 Jan, 2024 US11311554
Electronic Review 09 May, 2023 US11642355
Patent eGrant Notification 09 May, 2023 US11642355
Recordation of Patent eGrant 09 May, 2023 US11642355
Mail Patent eGrant Notification 09 May, 2023 US11642355
Recordation of Patent Grant Mailed 09 May, 2023 US11642355
Patent Issue Date Used in PTA Calculation 09 May, 2023 US11642355
Email Notification 09 May, 2023 US11642355
Email Notification 20 Apr, 2023 US11642355



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Testosterone Cypionate Generics

Several generic applications have been filed for Testosterone Cypionate. The first generic version for Testosterone Cypionate was by Watson Pharmaceuticals Inc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Eugia Pharma Specialities Ltd and was approved on Oct 20, 2023.

Given below is the list of companies who have filed for Testosterone Cypionate generic.


1. PFIZER

Pfizer Inc has filed for 3 different strengths of generic version for Testosterone Cypionate. All of these versions come by the name DEPO-TESTOSTERONE. Given below are the details of the strengths of this generic introduced by Pfizer.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG/ML injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
100MG/ML

(reference standard)

(reference listed drug)

injectable Prescription INJECTION AO Approved Prior to Jan 1, 1982
200MG/ML

(reference standard)

(reference listed drug)

injectable Prescription INJECTION AO Approved Prior to Jan 1, 1982


2. CIPLA

Cipla Ltd has filed for 2 different strengths of generic version for Testosterone Cypionate. Given below are the details of the strengths of this generic introduced by Cipla.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/ML injectable Prescription INJECTION AO Jun 19, 2018
100MG/ML injectable Prescription INJECTION AO Jun 19, 2018


3. WILSHIRE PHARMS INC

Wilshire Pharmaceuticals Inc has filed for 1 generic for Testosterone Cypionate. Given below are the details of the strengths of this generic introduced by Wilshire Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/ML injectable Prescription INJECTION AO Apr 24, 2019


4. RISING

Rising Pharma Holding Inc has filed for 1 generic for Testosterone Cypionate. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/ML injectable Discontinued INJECTION N/A Dec 11, 2006


5. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Testosterone Cypionate. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/ML injectable Prescription INJECTION AO Jul 15, 2010
100MG/ML injectable Prescription INJECTION AO Jul 15, 2010


6. WATSON LABS

Watson Laboratories Inc has filed for 2 different strengths of generic version for Testosterone Cypionate. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/ML injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982
200MG/ML injectable Discontinued INJECTION N/A Approved Prior to Jan 1, 1982


7. XIROMED

Xiromed Pharma Espana Sl has filed for 2 different strengths of generic version for Testosterone Cypionate. Given below are the details of the strengths of this generic introduced by Xiromed.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/ML injectable Prescription INJECTION AO Apr 13, 2023
200MG/ML injectable Prescription INJECTION AO Apr 13, 2023


8. SANDOZ

Sandoz Inc has filed for 2 different strengths of generic version for Testosterone Cypionate. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/ML injectable Prescription INJECTION AO Aug 10, 2006
100MG/ML injectable Prescription INJECTION AO Aug 10, 2006


9. SUN PHARM INDS LTD

Sun Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Testosterone Cypionate. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/ML injectable Prescription INJECTION AO Jun 3, 2013
200MG/ML injectable Prescription INJECTION AO Jun 3, 2013


10. AM REGENT

American Regent Inc has filed for 1 generic for Testosterone Cypionate. Given below are the details of the strengths of this generic introduced by Am Regent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/ML injectable Prescription INJECTION AO Jun 16, 2017


11. HIKMA FARMACEUTICA

Hikma Farmaceutica (portugal) Sa has filed for 1 generic for Testosterone Cypionate. Given below are the details of the strengths of this generic introduced by Hikma Farmaceutica.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/ML injectable Prescription INJECTION AO May 1, 2012


12. WATSON PHARMS INC

Watson Pharmaceuticals Inc has filed for 1 generic for Testosterone Cypionate. Given below are the details of the strengths of this generic introduced by Watson Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/ML injectable Prescription INJECTION AO Approved Prior to Jan 1, 1982


13. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 2 different strengths of generic version for Testosterone Cypionate. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/ML injectable Prescription INJECTION AO Oct 20, 2023
200MG/ML injectable Prescription INJECTION AO Oct 20, 2023


14. PADAGIS US

Padagis Us Llc has filed for 1 generic for Testosterone Cypionate. Given below are the details of the strengths of this generic introduced by Padagis Us.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/ML injectable Prescription INJECTION AO Jan 31, 2005